CD4CD25 + Foxp3 + Regulatory T cells protect endothelial function impaired by Oxidized Low Density Lipoprotein via the KLF-2 transcription factor

Cellular Physiology and Biochemistry

Volumn 28, Issue 4, 2011, Pages 639-648

  Li, Ming ^a   Wang, Xiang ^a   Fu, Wenbo ^c   He, Shaolin ^a   Li, Dazhu ^a,b   Ke, Qinmei ^b  

^a Union Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Human umbilical vein endothelial cells; Kr ppel Like Factor 2; Oxidized Low Density Lipoprotein

Indexed keywords

CD3 ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; KRUPPEL LIKE FACTOR 2; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; VASCULAR CELL ADHESION MOLECULE 1; CD4 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL CONTACT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; ENDOTHELIUM; GENE INDUCTION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ANTIGENS, CD4; CELLS, CULTURED; ENDOTHELIAL CELLS; FORKHEAD TRANSCRIPTION FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPOPROTEINS, LDL; NITRIC OXIDE SYNTHASE TYPE III; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES, REGULATORY; VASCULAR CELL ADHESION MOLECULE-1;

EID: 83755183460     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335759     Document Type: Article

References (28)

1. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z: Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006;12:178-180. (Pubitemid 43214743)
2. Yang KP, Li D, Luo M, Hu Y: Generation of HSP60 specific regulatory T cell and effect on atherosclerosis. Cell Immunol 2006;243:90-95. (Pubitemid 46437321)
3. Lin J, Li M, Wang Z, He S, Ma X, Li D: The role of CD4+CD25+regulatory T cells in macrophage-derived foam cells formation. J Lipid Res 2010;51:1208-1217.
4. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J: Role of naturally occurring CD4+CD25+regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:893-900. (Pubitemid 46606722)
5. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell 2008;133:775-787. (Pubitemid 351707693)
6. Quillard T, Devallière J, Coupel S, Charreau B: Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction. Biochem Pharmacol 2010;80:2032-2041.
7. Pober JS: Endothelial activation: intracellular signaling pathways. Arthritis Res 2002;4:S109-116.
8. Dekker RJ, Boon RA, Rondaij MG, Kragt A, Volger OL, Elderkamp YW, Meijers JC, Voorberg J, Pannekoek H, Horrevoets AJ: KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 2006;107:4354-4363. (Pubitemid 43801361)
9. McConnell BB, Yang VW: Mammalian Krüppel-like factors in health and diseases. Physiol Rev 2010;90:1337-1381.
10. He S, Li M, Ma X, Lin J, Li D: CD4+CD25+Foxp3+ Regulatory T Cells Protect the Proinflammatory Activation of Human Umbilical Vein Endothelial Cells. Arterioscler Thromb Vasc Biol 2010;30:2621-2630.
11. Wagner AH, Gebauer M, Pollok-Kopp B, Hecker M: Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 2002;99:520-525. (Pubitemid 34533087)
12. Holven KB, Aukrust P, Holm T, Ose L, Nenseter MS: Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 2002;22:699-703. (Pubitemid 34408756)
13. Li M, Che J, Li YS, Feng YB, Zeng QT: Folic acid reduces chemokine MCP-1 release and expression in rats with hyperhomocystinemia. Cardiovasc Pathol 2007;16:305-309. (Pubitemid 47376966)
14. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4+CD25+T cells with regulatory properties from human blood. J Exp Med 2001;193:1303-1310. (Pubitemid 32524780)
15. Levings MK, Sangregorio R, Roncarolo MG: Human CD25+CD4+T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001;193:1295-1302.
16. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314. (Pubitemid 24046692)
17. Hansson GK: Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1685-1695.
18. Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-581.
19. Pober JS, Sessa WC: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007;7:803-815. (Pubitemid 47480307)
20. Bieker JJ: Isolation, genomic structure and expression of human erythroid Kruppel-like factor (EKLF). DNA Cell Biol 1996;15:347-352.
21. Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K,Vaughan DE, Gimbrone MA Jr, Balasubramanian V, Garcia-Cardena G, Jain MK: Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 2005;96:e48-e57.
22. Steinberg D, Witztum JL: Is the oxidative modification hypothesis relevant to human atherosclerosis? Circulation 2002;105:2107-2111.
23. Galle J, Hansen-Hagge T, Wanner C, Seibold S: Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006;185:219-226.
24. Huddleson JP, Srinivasan S, Ahmad N, Lingrel JB: Fluid shear stress induces endothelial KLF2 gene expression through a de?ned promoter region. Biol Chem 2004;385:723-729. (Pubitemid 39255630)
25. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, Garcia-Cardena G: Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 2005;280:26714-26719. (Pubitemid 41040703)
26. Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, Banerjee P, Kumar A, Jain MK: Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 2005;112:720-726. (Pubitemid 41099052)
27. Bellosta S, Ferri N, Bernini F, Paoletti R, Corsini A: Non-lipid-related effects of statins. Ann Med 2000;32:164-176. (Pubitemid 30237561)
28. Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118. (Pubitemid 40261799)